Home › Asset managers › Compare 2024-2025 › DWS vs Lincoln Financial
DWS 2024-2025 · Lincoln Financial 2024-2025 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 60,514 | 54,275 | 1,902 | 4,337 | 96.6% | 94.1% |
| Board proposals | 48,804 | 43,550 | 1,591 | 3,663 | 96.5% | 93.8% |
| E&S shareholder proposals | 254 | 106 | 43 | 105 | 71.1% | 60.4% |
| Other items | 11,456 | 10,619 | 268 | 569 | 97.5% | 95.8% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
5,254 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | DWS | Lincoln Financial |
|---|---|---|---|---|---|---|
| SBI CARDS AND PAYMENT SERVICES LTD. | February 6, 2025 | Amend SBI Card Employee Stock Option Plan 2023 Compensation |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| SCPHARMACEUTICALS INC. | June 3, 2025 | Election of Class II Directors: William T. Abraham, M.D. Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 1 fund |
| SDIC POWER HOLDINGS CO. LTD. | April 17, 2025 | Approve Provision of Guarantee Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| SEB SA | May 20, 2025 | Reelect Brigitte Forestier as Director Director Elections |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| SEI INVESTMENTS CO. | May 28, 2025 | Election of Directors: William M. Doran Director Elections |
Board | For | AGAINST 4 funds |
FOR 7 funds |
| SEINO HOLDINGS CO. LTD. | June 26, 2025 | Elect Director Taguchi, Yoshitaka Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| SENECA FOODS CORP. | August 8, 2024 | Election of Directors: Election of three directors to serve until the Annual Meeting of Shareholders in 2027 and until each of their successors is duly elected and shall qualify: Linda K. Nelson Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 1 fund |
| SERA PROGNOSTICS INC. | June 5, 2025 | Election of Directors: Jane F. Barlow, M.D. Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 2 funds |
| SERA PROGNOSTICS INC. | June 5, 2025 | Election of Directors: Mansoor Raza Mirza, M.D. Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 2 funds |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Attribution of Profit and Loss During the Transition Period Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Authorization of the Board to Handle All Related Matters Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Company's Eligibility for Acquisition by Issuance of Shares Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Completeness and Compliance of Implementation of Legal Proceedings of the Transactions and Validity of the Submitted Legal Documents Regarding This Transaction Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Confidentiality Measures and Confidentiality Systems Adopted for This Transaction Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Contractual Obligations and Liability for Breach of Contract During Ownership Transfer Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Distribution Arrangement of Undistributed Earnings Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Impact of Dilution of Current Returns on Major Financial Indicators, the Relevant Measures to be Taken Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Independence of Appraiser, the Validity of Hypothesis, the Relevance of Valuation Purpose and Approach as Well as the Fairness of Pricing Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Issue Amount Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Issue Manner and Target Subscribers Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Listing Exchange Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Lock-Up Period Arrangement Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Price Adjustment Mechanism Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Pricing Basis and Issue Price Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Purchase and Sale of Assets Within the Twelve Months Prior to the Transaction Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Relevant Audit Reports, Review Report and Evaluation Report of This Transaction Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Report (Draft) and Summary on Company's Acquisition by Issuance of Shares Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Resolution Validity Period Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Signing of Conditional Share Subscription Agreement Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Signing of Supplemental Agreement for Conditional Share Subscription Agreement Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Stock Price Fluctuations Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Transaction Complies with Article 4 of the Guidelines for the Supervision of Listed Companies No. 9 Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Transaction Complies with Articles 11 and 43 of the Measures for the Administration of Major Asset Restructuring of Listed Companies Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Transaction Constitutes as Major Assets Restructuring but not Restructuring for Listing Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Transaction Does Not Constitute as Related-Party Transaction Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Transaction Does Not Fall Under the Circumstances Specified in Article 12 of the Guidelines for the Supervision of Listed Companies No. 7 Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Transaction Method and Payment Arrangement Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Transaction Plan Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Transaction Price of Target Assets Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| SERES GROUP CO. LTD. | October 28, 2024 | Approve Type and Par Value of Share Issuance Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| SERVICE PROPERTIES TRUST | June 13, 2025 | Election of Trustees. Nominees (for Independent Trustee): Donna D. Fraiche Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| SERVICE PROPERTIES TRUST | June 13, 2025 | Election of Trustees. Nominees (for Managing Trustee): Adam Portnoy Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| SEZZLE INC. | November 19, 2024 | Election of Directors: Paul Paradis Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 1 fund |
| SFL CORPORATION LTD. | May 8, 2025 | Elect Director James O'Shaughnessy Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 3 funds |
| SG MICRO CORP. | September 19, 2024 | Elect Lin Lin as Director Director Elections |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| SHAN XI HUA YANG GROUP NEW ENERGY CO. LTD. | January 16, 2025 | Approve Application of Credit Lines Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| SHANDONG GOLD MINING CO. LTD. | November 21, 2024 | Approve Guarantee Provided by the Company for Financing of its Controlling Subsidiary, Cardinal Namdini Mining Limited Capital Structure |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| SHANDONG GOLD MINING CO. LTD. | January 14, 2025 | Approve Estimated Guarantee Amount Provided by Shanjin International (a Controlling Subsidiary of the Company) to its Subsidiaries Capital Structure |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| SHANDONG GOLD MINING CO. LTD. | June 11, 2025 | Approve Guarantee Facility for the Hong Kong Subsidiary Capital Structure |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| SHANDONG LINGLONG TYRE CO. LTD. | May 15, 2025 | Approve Credit Line Application and Guarantee Matters Capital Structure |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| SHANDONG SUNPAPER CO. LTD. | December 27, 2024 | Approve Application of Credit Lines Capital Structure |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| SHANDONG SUNPAPER CO. LTD. | December 27, 2024 | Approve Project Financing Through Syndicated Loan Capital Structure |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| SHANDONG SUNPAPER CO. LTD. | December 27, 2024 | Approve Provision of Guarantee Capital Structure |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| SHANGHAI ELECTRIC GROUP COMPANY LTD. | May 30, 2025 | Approve Provision of Guarantee by Shanghai Electric New Energy Development Co., Ltd. for Gaotai Shanghai Electric New Energy Development Co., Ltd Capital Structure |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| SHANGHAI ELECTRIC GROUP COMPANY LTD. | May 30, 2025 | Approve Provision of Guarantee by Shanghai Electric Power Transmission and Distribution Engineering Co., Ltd. for Shanghai Electric Power Transmission and Distribution Engineering (Malaysia) Co., Ltd. Capital Structure |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| SHANGHAI ELECTRIC GROUP COMPANY LTD. | May 30, 2025 | Approve Provision of Guarantee by Shanghai Institute of Mechanical & Electrical Engineering Co., Ltd. for Shanghai Ouhai Energy Technology Co., Ltd. Capital Structure |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| SHANGHAI ELECTRIC GROUP COMPANY LTD. | May 30, 2025 | Approve Provision of Guarantee by Shenzhen Yinghe Technology Co., Ltd. for Huizhou Yinghe Technology Co., Ltd. Capital Structure |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO. LTD. | June 24, 2025 | Approve Additional Total Credit Applications Capital Structure |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO. LTD. | June 24, 2025 | Approve Grant of General Mandate to Register and Issue Corporate Bonds Capital Structure |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO. LTD. | June 24, 2025 | Approve Renewed and Additional Entrusted Loans/Borrowings Quota Capital Structure |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO. LTD. | June 24, 2025 | Approve Renewed and Additional Guarantee Quota Capital Structure |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| SHANGHAI PHARMACEUTICALS HOLDING CO. LTD. | June 26, 2025 | Approve Authorizations Regarding this Issuance to the Executive Committee of the Board Capital Structure |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| SHANGHAI PHARMACEUTICALS HOLDING CO. LTD. | June 26, 2025 | Approve Face Value and Issuing Price of Bonds to be Issued and Scale of Issuance Capital Structure |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| SHANGHAI PHARMACEUTICALS HOLDING CO. LTD. | June 26, 2025 | Approve Guarantees Capital Structure |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| SHANGHAI PHARMACEUTICALS HOLDING CO. LTD. | June 26, 2025 | Approve Interest Rate of Bonds and Its Way of Determination Capital Structure |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| SHANGHAI PHARMACEUTICALS HOLDING CO. LTD. | June 26, 2025 | Approve Issuance of Debt Financing Products Capital Structure |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| SHANGHAI PHARMACEUTICALS HOLDING CO. LTD. | June 26, 2025 | Approve Listing Arrangements Capital Structure |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| SHANGHAI PHARMACEUTICALS HOLDING CO. LTD. | June 26, 2025 | Approve Measures to Guarantee Bonds Repayment Capital Structure |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| SHANGHAI PHARMACEUTICALS HOLDING CO. LTD. | June 26, 2025 | Approve Method of Issuance Capital Structure |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| SHANGHAI PHARMACEUTICALS HOLDING CO. LTD. | June 26, 2025 | Approve Method of Principal and Interest Repayment Capital Structure |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| SHANGHAI PHARMACEUTICALS HOLDING CO. LTD. | June 26, 2025 | Approve Period of Validity of the Resolution Capital Structure |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| SHANGHAI PHARMACEUTICALS HOLDING CO. LTD. | June 26, 2025 | Approve Satisfaction of Conditions for Issuing Corporate Bonds Capital Structure |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| SHANGHAI PHARMACEUTICALS HOLDING CO. LTD. | June 26, 2025 | Approve Target of Issuance and Arrangement of Placement to Shareholders of the Company Capital Structure |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| SHANGHAI PHARMACEUTICALS HOLDING CO. LTD. | June 26, 2025 | Approve Use of Proceeds Capital Structure |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| SHANGHAI PHARMACEUTICALS HOLDING CO. LTD. | June 26, 2025 | Approve Variety and Term of Bonds Capital Structure |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| SHANGHAI PHARMACEUTICALS HOLDING CO. LTD. | June 26, 2025 | Approve Way of Underwriting Capital Structure |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| SHANGHAI PUTAILAI NEW ENERGY TECHNOLOGY CO. LTD. | January 6, 2025 | Approve Provision of Guarantees Capital Structure |
Board | For | AGAINST 4 funds |
FOR 1 fund |
| SHANGHAI PUTAILAI NEW ENERGY TECHNOLOGY CO. LTD. | January 6, 2025 | Elect Huang Yong as Director Director Elections |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| SHANXI LU'AN ENVIRONMENTAL ENERGY DEVELOPMENT CO. LTD. | October 29, 2024 | Approve Financial Assistance Provision Capital Structure |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| SHANXI LU'AN ENVIRONMENTAL ENERGY DEVELOPMENT CO. LTD. | May 29, 2025 | Approve Provision of Financial Assistance Capital Structure |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| SHANXI LU'AN ENVIRONMENTAL ENERGY DEVELOPMENT CO. LTD. | May 29, 2025 | Approve Provision of Financial Assistance for Subsidiary Capital Structure |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| SHENWAN HONGYUAN GROUP CO. LTD. | December 19, 2024 | Approve Provision of Guarantee for Hongyuan Hengli (Shanghai) Industrial Co., Ltd. Capital Structure |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| SHENZHEN INOVANCE TECHNOLOGY CO. LTD. | September 23, 2024 | Approve Authorization of the Board to Handle All Related Matters Compensation |
Board | For | AGAINST 5 funds |
FOR 1 fund |
| SHENZHEN INOVANCE TECHNOLOGY CO. LTD. | September 23, 2024 | Approve Draft and Summary of Equity Incentive Plan Compensation |
Board | For | AGAINST 5 funds |
FOR 1 fund |
| SHENZHEN INOVANCE TECHNOLOGY CO. LTD. | September 23, 2024 | Approve Methods to Assess the Performance of Plan Participants Compensation |
Board | For | AGAINST 5 funds |
FOR 1 fund |
| SHISEIDO CO. LTD. | March 26, 2025 | Elect Director Fujiwara, Kentaro Director Elections |
Board | For | AGAINST 7 funds |
FOR 2 funds |
| SICHUAN KELUN PHARMACEUTICAL CO. LTD. | January 15, 2025 | Approve Financing Capital Structure |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| SICHUAN KELUN PHARMACEUTICAL CO. LTD. | May 19, 2025 | Approve Bill Pool Business Capital Structure |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| SICHUAN KELUN PHARMACEUTICAL CO. LTD. | May 19, 2025 | Approve Issuance of Non-Financial Corporate Debt Financing Instruments Capital Structure |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| SIEMENS HEALTHINEERS AG | February 18, 2025 | Approve Remuneration Policy Compensation |
Board | For | AGAINST 8 funds |
FOR 1 fund |
| SIEMENS LTD. | February 12, 2025 | Reelect Deepak S. Parekh as Director Director Elections |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| SILVACO GROUP INC. | May 22, 2025 | Election of 9 Director Nominees: Iliya Pesic Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| SIME DARBY BERHAD | November 14, 2024 | Elect Lee Cheow Hock Lawrence as Director Director Elections |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| SIME DARBY BERHAD | November 14, 2024 | Elect Mohamad Idros Mosin as Director Director Elections |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| SIME DARBY BERHAD | November 14, 2024 | Elect Moy Pui Yee as Director Director Elections |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| SIME DARBY BERHAD | November 14, 2024 | Elect Samsudin Osman as Director Director Elections |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| SINO LAND COMPANY LTD. | October 23, 2024 | Elect Allan Zeman as Director Director Elections |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| SK BIOSCIENCE CO. LTD. | March 26, 2025 | Approve Financial Statements and Allocation of Income Capital Structure |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| SK INC. | March 26, 2025 | Approve Financial Statements and Allocation of Income Capital Structure |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| SK INC. | March 26, 2025 | Approve Total Remuneration of Inside Directors and Outside Directors Compensation |
Board | For | AGAINST 2 funds |
FOR 1 fund |
← Previous Page 13 of 53 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 25, 2026 from SEC Form N-PX filings.